Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 3
1962 1
1963 2
1964 1
1967 3
1968 2
1969 5
1971 6
1972 8
1973 6
1974 7
1975 10
1976 9
1977 17
1978 15
1979 12
1980 11
1981 13
1982 18
1983 19
1984 17
1985 22
1986 39
1987 21
1988 29
1989 23
1990 22
1991 32
1992 33
1993 24
1994 25
1995 21
1996 30
1997 39
1998 29
1999 31
2000 35
2001 34
2002 37
2003 38
2004 50
2005 45
2006 38
2007 32
2008 43
2009 60
2010 56
2011 61
2012 56
2013 62
2014 49
2015 48
2016 52
2017 48
2018 48
2019 36
2020 42
2021 44
2022 38
2023 38
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,599 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry.
Cohen O, Kenet G, Levy-Mendelovich S, Tzoran I, Brenner B, De Ancos C, López-Miguel P, Varona JF, Catella J, Monreal M; and the RIETE investigators. Cohen O, et al. Among authors: brenner b. J Thromb Thrombolysis. 2024 Apr;57(4):710-720. doi: 10.1007/s11239-024-02957-4. Epub 2024 Mar 16. J Thromb Thrombolysis. 2024. PMID: 38491267
Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
Russell B, Beyer K, Lawlor A, Roobol MJ, Venderbos LDF, Remmers S, Briers E, MacLennan SJ, MacLennan S, Omar MI, Van Hemelrijck M; PIONEER Consortium. Russell B, et al. Eur Urol Open Sci. 2023 Dec 19;59:27-29. doi: 10.1016/j.euros.2023.11.004. eCollection 2024 Jan. Eur Urol Open Sci. 2023. PMID: 38298764 Free PMC article.
Concerns about the ALIFE2 trial.
Grandone E, Brenner B, Piazza G. Grandone E, et al. Among authors: brenner b. Lancet. 2024 Jan 20;403(10423):246. doi: 10.1016/S0140-6736(23)02338-3. Lancet. 2024. PMID: 38245243 No abstract available.
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry.
Ortega AG, Jiménez D, Pedro-Tudela A, Pérez-Ductor C, Fernández-Capitán C, Falgá C, Skride A, Siniscalchi C, Weinberg I, Monreal M; RIETE investigators. Ortega AG, et al. Arch Bronconeumol. 2024 Mar;60(3):143-152. doi: 10.1016/j.arbres.2023.12.016. Epub 2024 Jan 3. Arch Bronconeumol. 2024. PMID: 38220587 English, Spanish.
1,599 results